secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lite Strategy, Inc. (LITS)
CIK:        0001262104
Form:       8-K
Filed at:   2023-01-06T23:59:59+00:00
Accession:  0001193125-23-003583
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

MEI Pharma shareholders approve reverse stock split authorization and other proposals at annual meeting
--------------------------------------------------------------------------------

- Thomas C. Reynolds elected to Board with 49M for, 5.3M withheld, 30.3M broker non-votes.
- Amended 2008 Equity Plan approved (44.2M for, 5.9M against) to increase share pool.
- Reverse stock split authorized at ratio between 1:10 and 1:20, Board to set ratio by June 30, 2023.
- Advisory vote on executive compensation passed (43.4M for, 6.8M against).
- Ratification of BDO USA as auditor approved (78.7M for, 0.7M against).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1262104/000119312523003583/0001193125-23-003583-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1262104/000119312523003583/d425652d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-003583

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer